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Background: The chronic care model (CCM) has been widely used in a variety of health
care settings to guide system improvement for chronic illness care, including diabetes
care. However, the evidence base for the specific components of the model has not been
systematically reviewed. This review aimed at examining the extent to which interven-
tions featuring the CCM components improve diabetes care and determining the relative
effectiveness of different CCM components. Methods: We systematically searched
MEDLINE (1966 to December 2004), the Cochrane Effective Practice and Organisation of
Care and the Cochrane Controlled Trials Register to identify interventions featuring one
or more system components of the CCM for diabetes care. Outcome measures included
HbA1c, blood pressure and blood lipid control. We used random-effects meta-analysis
and meta-regression for quantitative synthesis of data. Results: In all, 69 studies (43
randomized controlled trials and 26 controlled before–after studies) met inclusion criteria
and were included in this review. Overall, included studies reported a mean reduction of
0.46% (95% CI 0.38, 0.54) in HbA1c, mean reduction of 2.2 (95% CI 0.9, 3.5)mmHg in
systolic blood pressure, mean reduction of 1.3 (95% CI 0.6, 2.1)mmHg in diastolic blood
pressure and mean reduction of 0.24 (95% CI 0.06, 0.41)mmol/L in total cholesterol. For
specific CCM components, interventions that addressed delivery system design reported
the largest improvements in patient outcomes, followed by those employing a self-
management support component. Interventions involving decision support or clinical
information systems reported relatively smaller effect sizes. Conclusions: Interventions
featuring CCM components for diabetes care produced small-to-moderate improve-
ments in a range of patient intermediate outcomes. The findings support the concept of
the CCM in which the state of development of various aspects of primary care service
systems defined in this model appear to be important factors in the quality of care
provided to people with diabetes.
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Introduction
Development of the chronic care model
The chronic care model (CCM), a conceptual
model for improving chronic illness care, was first
described in an article published in 1998 by
Wagner (1998). It was developed on the basis of
an examination of literature which reported suc-
cessful practice and system changes leading to
improved chronic illness care, and on a consensus
among experts (Wagner et al., 1996; 1999).
The CCM describes the interacting system
components required for providing high-quality
chronic illness care (see Figure 1). Within a health
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care system, there are four components at the
practice level: self-management support, delivery
system design, decision support and clinical infor-
mation systems. A higher level component, orga-
nization of health care, plays an overarching role
to guide practice-level development. A broader
component, the community, provides necessary
resources and policies linked to chronic illness
care. The development and integration of these
components is seen to foster productive interac-
tions between prepared, proactive health providers
and informed, activated patients. As a result,
patients’ outcomes are expected to be improved.
The CCM has gained considerable attention
and has been used in a variety of health care
organizations. In the United States, more than
100 health care organizations, including hospital
systems, academic health centres and community
health systems, have completed the national
chronic condition quality improvement pro-
grammes using the CCM framework (Wagner
et al., 2001a). In Canada, the CCM has been
applied in the Capital Health Region of Victoria,
British Columbia, to develop and evaluate a
region-wide initiative to improve the outcomes of
people with diabetes and those at risk of diabetes
(Fulton et al., 2001). It was suggested that the
CCM could help the National Health Service in
the UK to focus on wider policies for generic
chronic illness care, rather than implementation
of service frameworks for selected chronic con-
ditions (Lewis and Dixon, 2004). Furthermore,
the CCM has been adopted and expanded by the
WHO to develop an Innovative Care for Chronic
Conditions framework, which serves as a basis for
policy development and system redesign in global
contexts (Epping-Jordan et al., 2004).
Evidence base for the chronic care model
Several published observational studies have
demonstrated the implementation of the CCM in
clinical practices and observed improved quality of
care (Wagner et al., 2001b; Bonomi et al., 2002;
Sperl-Hillen et al., 2004; Wu et al., 2003). However,
these evaluations employed uncontrolled before-
and-after study designs, making it difficult to con-
clude whether the changes in patient care resulted
from the interventions or from other un-measured
factors. Two recently published experimental stu-
dies provide stronger evidence in support of CCM-
oriented interventions (Piatt et al., 2006; Landon
et al., 2007). However, the generalizability of these
two US-based studies is not clear. In addition to
this relatively limited evidence base for explicitly
CCM-oriented interventions, the impact of pri-
mary care system-oriented interventions relating
to specific components of the CCM has been
examined by many studies across the world. An
attempt to systematically review the impact of
such interventions in the context of diabetes care
has been made by Bodenheimer et al. (2002). They
re-analysed studies identified by a Cochrane
review that assessed the effects of interventions
Figure 1 The chronic care model (CCM) (Wagner, 1998). Reproduced with permission from the American College of
Physicians.
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targeting health professionals and the structure of
care on diabetes management in primary health
care (Renders et al., 2001). However, the scope
designated in the CCM is broader than that cov-
ered by the Cochrane review, where some relevant
studies might have been systematically excluded
from the analysis by Bodenheimer. Another recent
systematic review took a similar approach, but
included impacts on a wide range of chronic dis-
ease outcomes (Zwar et al., 2006). The effective-
ness of interventions across the scope of the CCM
requires further study.
Aims of this review
1) To systematically identify studies of diabetes
care that assess effects of interventions featur-
ing the CCM components;
2) To examine the extent to which interventions
featuring the CCM components improve
diabetes care and
3) To determine the relative effectiveness of
different CCM components on diabetes care.
Methods
Criteria for selecting studies
Types of studies
Two types of studies were included: rando-
mized controlled trials (RCTs) and controlled
before-and-after studies (CBAs). Inclusion of
non-randomized controlled studies such as CBAs
in reviews has been recommended by the
Cochrane Effective Practice and Organisation of
Care Group (2006), as many organizational and
professional interventions may not be feasible to
be evaluated in a RCT.
Types of populations
Participants in studies were required to meet
the following three criteria:
1) Diagnosis of type 1 or type 2 diabetes;
2) Aged 16 years or more;
3) Non-hospitalized patients, who received care
in a primary care, outpatient or community
setting.
Studies that focused on gestational diabetes
were excluded.
Classification of interventions
Studies included are those with interventions
targeting organizational systems, management,
professionals or patients using systematically
developed approaches for diabetes care (detailed
in Table 1). Studies aimed exclusively at eva-
luations of single treatment methods (eg,
psychotherapy or specific drugs) and drug com-
pliance studies were excluded. In line with the
concept of the CCM, intervention components
were classified into six categories (Table 1). In
general, the control groups in included studies
received ‘usual care’ or ‘standard care’.
Outcome measures
Intermediate patient outcomes:
> HbA1c control;
> Systolic and diastolic blood pressure control;
> Blood lipid control (including total cholesterol,
HDL, LDL and triglycerides).
We only included patient outcome data
obtained by chart reviews, direct clinical exam-
inations or through clinical information systems.
Data from patient or provider self-reporting were
excluded.
Search strategy for identification of studies
a) The following electronic databases were
searched:
Cochrane Effective Practice and Organisation
of Care (EPOC) specialized register, the
Cochrane Controlled Trials Register (CCTR)
(Cochrane Library Issue 2, 2005) and MED-
LINE (1966 to December 2004).
We adapted search strategies recommended
by the Cochrane Metabolic and Endocrine
Disorders Group (2003), Cochrane Effective
Practice and Organisation of Care (2004), and
other Cochrane reviews (Giuffrida et al., 1999;
Renders et al., 2001; Griffiths et al., 2005;
Roger, 2004) (search strategy available on
request from the authors).
b) References of published systematic reviews
related to diabetes care.
We identified systematic reviews or meta-
analyses related to diabetes care by searching
two electronic databases in the Cochrane
Library (keyword ‘diabetes mellitus’ was
used): the Cochrane Database of Systematic
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Reviews (CDSR) and Database of Abstracts
of Reviews of Effects (DARE). Systematic
reviews (or meta-analyses) with their aims
related to any areas defined in Table 1 were
retrieved to obtain their reference lists.
c) Reference list of each retrieved article was
scanned to identify further studies.
Review process and data abstraction
Initially, all abstracts of studies identified by
electronic and hand search were screened by a
single reviewer (DS) against the inclusion criteria,
to identify potential studies that merited full-text
reviews. The author repeated this process to
ensure the reliability for selection into the review.
The full articles of all studies for which abstracts
were identified as possibly meeting the inclusion
criteria at either screening were retrieved for
further assessment.
At the full-text level, a standardized abstraction
form was used by the single reviewer to extract
information on study characteristics, interventions,
outcomes and design quality. For each study, the
reviewer repeated the processes of classifying
interventions and appraising study quality.
Any discrepancies between the initial and repeat
process were reviewed and resolved.
When a single study led to multiple publica-
tions, all relevant papers were reviewed together
and one single form was used to collect data.
When a single study involved several inter-
vention arms (versus a control arm), each pair of
intervention and control arms was considered as
a separate comparison. For example, if a study
composed of three intervention arms and one
control arm, three data abstraction forms were
used for each of three comparisons.
Outcomes in each study, where possible, were
reported in the following ways:
> Patient outcomes (HbA1c, blood pressure, total
cholesterol, HDL, LDL and triglycerides):
mean and standard deviation for each of the
intervention and control arms before and after
the intervention.
Table 1 Classification of interventions
Intervention component Feature
Organizational influencea > Organizational goals and resources for chronic illness care
> Quality improvement strategies
> Incentives
Community linkages > Linking patients to outside resources
> Activities with community-based organizations
> Professionals working out in the community
Self-management support > Interventions based on technological aids to promote self-care
> Self-help groups
> Family-oriented supports
> Motivational support
> Behaviour therapy
Decision support > Practice guidelines
> Provider education
> Involvement of specialists in improving primary care
Delivery system design > Practice team functioning
> Patient care planning and follow-up
> Coordination between primary care and specialist services
Clinical information systems > Disease registry
> Reminders to providers
> Feedback to providers
aWe use ‘organizational influence’ to replace the original term ‘ health care organizations’ in the chronic care
model (CCM). As ‘health care organizations’ and ‘health care systems’ are usually used interchangeably, our
modification would allow the six components in the CCM to be termed logically as system components.
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Quality assessment
As part of data collection, quality assessment
for each included study was conducted using
a standardized assessment tool. The tool was
developed by the Effective Public Health Practice
Project (2006) and consists of six quality criteria:
> Selection bias
> Allocation bias
> Confounders
> Blinding of outcome assessors
> Data collection methods
> Withdrawals and dropouts
Each of these six criteria was rated as ‘strong’,
‘moderate’ or ‘weak’ in quality for a given study
using predetermined standards. Each study also
received an overall assessment of strong, moder-
ate or weak quality by the following definition:
(1) strong – at least four of six criteria were rated
as strong, with no weak ratings; (2) moderate –
one criterion was rated as weak; and (3) weak –
two or more criteria were rated as weak.
Statistical analysis
Following the method employed in a recent
systematic review of quality improvement stra-
tegies for diabetes care (Shojania et al., 2006),
we calculated the effect size (and its standard
error) for each single study using the following
formulas:
> Effect size (mean difference)5 difference in
postintervention values between intervention
and control groups for mean patient outcomes.
In this article, we simply state effect sizes for
different patient outcomes in the following
way: reduction in HbA1c, blood pressure, total
cholesterol, LDL, triglycerides, and increase
in HDL, as those directions represent an
improvement.
> Standard error of effect size5
Sp2
p
ð1=Niþ 1=NcÞ with
Sp2 ¼ ½ðNi 1ÞSi2 þ ðNc 1ÞSc2Þ=
ðNiþNc 2Þ;
where Ni and Nc are the intervention and control
group sample sizes, respectively, and Si and Sc
are the intervention and control group sample
standard errors (Normand, 1999).
In some included studies interventions were
allocated at the clinician or clinic level but data
were collected at the patient level. This meant
there was some clustering of patients at the
clinician (or clinic) level, and adjustment for
clustering was required to avoid overstating the
significance of differences. In order to deal with
the clustering, we calculated an effective sample
size for each such study: Neffective5 (k3m)/
[11(m2 1)3 ICC], where k is the number of
clusters and m the number of patients per cluster;
and ICC refers to the intracluster correlation
coefficient (Shojania et al., 2006). We imputed the
ICC value as 0.035 based on previous empirical
estimations (Campbell et al., 2001).
We used a random-effects meta-analysis to esti-
mate pooled mean effect sizes among included
studies. A test for heterogeneity was performed
and indicated evidence of statistical heterogeneity
(for patient HbA1c results, Cochran’s Q5 4341,
P50.001). The random-effects meta-analysis allows
for statistical heterogeneity between studies by
assuming that the true effects in the individual
studies differ from each other (Normand, 1999).
We used a random-effects meta-regression to
formally test whether specific study features
influenced the magnitude of the effect sizes across
studies. Meta-regression is a useful technique to
investigate sources of heterogeneity with respect
to clinical diversity (eg, participants and inter-
ventions) and methodological diversity (eg, ran-
domization and blinding) of studies. The specific
features considered as potentially important
sources of clinical and methodological hetero-
geneity for studies in this review included base-
line levels of patient outcomes, study designs
(RCTs versus CBAs), methodological quality and
the number of intervention components.
Potential publication bias was explored using
an inverted funnel plot for patient HbA1c out-
come (Lau et al., 1997). All data analyses were
conducted using Stata (version 9.2, College
Station, TX, USA).
Results
Search results
In all, 615 abstracts were initially identified by
electronic and hand search (Figure 2). Of those
abstracts, 90 met our explicit inclusion criteria and
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their full-texts were retrieved for data abstraction.
During the full-text review, 25 papers failed to
meet inclusion criteria and the remaining 65 papers
were included for the current review. These
65 papers (listed at the end of this paper) reported
62 studies, with a total of 69 comparisons.
Characteristics of included studies
Studies conducted in 15 countries were inclu-
ded (Table 2). Nearly half were from the US,
followed by the Netherlands and the UK. In all,
18% of included studies were conducted among
selected patients with poor control of diabetes,
and 10% among socioeconomically disadvant-
aged populations. A total of 39 studies (63% of
total) were RCTs and 23 (37%) were CBAs. A
detailed summary of each included study is
available on request from the authors.
Types and numbers of components used
in interventions
Around half of the included comparisons
used decision support, self-management support,
delivery system design or clinical information
615 abstracts identified
563 identified by electronic search 
52 identified from references of published 
 reviews
90 Full papers of potentially relevant
studies retrieved
525 abstracts rejected 
63 study designs did not meet inclusion criteria
128 populations or conditions did not meet
inclusion criteria 
176 clinical drug or procedure trials
70 outcomes did not meet inclusion criteria 
88 reviews, editorials or case reports 
25 Papers rejected
12 outcomes did not meet inclusion criteria
8 interventions did not meet inclusion criteria
5 study designs did not meet inclusion criteria
65 papers reporting on 62 studies (69
comparisons) 
Figure 2 Search results
Table 2 Characteristics of included studies and comparisonsa
Characteristics Number (%) of studies Number (%) of comparisons
(n562) (n569)
Country
US 30 (48%) 34 (49%)
The Netherlands 9 (15%) 11 (16%)
UK 7 (11%) 7 (10%)
Australia 2 (3%) 3 (4%)
Other countries 14 (23%) 14 (21%)
Population
Selected patients with poor control 11 (18%) 12 (17%)
Socioeconomically disadvantaged 6 (10%) 7 (10%)
Year of publication
1980s 2 (3%) 4 (6%)
1990s 32 (52%) 31 (45%)
2000–2004 28 (45%) 34 (49%)
Intervention duration (years), median (range) 1 (0.25–9) 1 (0.25–9)
Sample size, median (range) – 265 (28–22971)
Study design
RCTs 39 (63%) 43 (62%)
CBAs 23 (37%) 26 (38%)
a Full references of included studies are list at the end of this paper.
RCTs: randomized controlled trials; CBAs: controlled before-and-after studies.
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systems in their interventions (Table 3). In con-
trast, only three comparisons included organiza-
tional influence as part of their interventions and
two employed community linkages.
In all, 28% of included studies reported inter-
ventions on a single system component, 48% on
two components, and 20% on three components.
The maximum number of components targeted
by an intervention was four (4% of all studies).
Methodological quality
Overall, the methodological quality of RCTs was
more rigorous than that of CBAs. Of the 39 RCTs,
23 (59%) were rated as strong in quality, 11 (28%)
as moderate and only 5 (13%) as weak. In contrast,
13% of CBAs were rated as strong in quality, 39%
as moderate and 49% as weak in quality.
Impact of different intervention components
on diabetes care
Impact on patient outcomes
Effects of different intervention components on
HbA1c control are shown in Table 4. Forty-six
comparisons had sufficient data to allow for cal-
culation of effect sizes in terms of reduction in
HbA1c. Overall, the mean reduction in HbA1c
was 0.46% (95% CI 0.38, 0.54). RCTs tended to
report smaller effect sizes than CBAs (0.38%
versus 0.68%, P5 0.01).
Table 3 Types of chronic care model components used in interventions
CCM component No. of comparisons
RCTs
No. of comparisons
CBAs
Combined % of total
(n569)
Organisational influence 1 2 3 4
Community linkages 1 1 2 3
Self-management support 27 8 35 51
Decision support 20 18 38 55
Delivery system design 19 12 31 45
Clinical information systems 12 18 30 44
RCTs: randomized controlled trials; CBAs: controlled before-and-after studies.
Table 4 Effects of different intervention components on HbA1c (%) control
Intervention component Pooled mean reduction in HbA1c (95% CI), n5number of comparisons
RCTs CBAs Total
Organizational influence – 0.69 (0.27, 1.11) 0.69 (0.27, 1.11)
n50 n5 2 n52
Community linkages – 0.30 (0.28, 0.32) 0.30 (0.28, 0.32)
n50 n5 1 n51
Self-management support 0.39 (0.30, 0.48) 0.68 (0.47, 0.89) 0.46 (0.38, 0.55)
n522 n5 6 n528
Decision support 0.33 (0.11, 0.55) 0.65 (0.36, 0.95) 0.44 (0.28, 0.60)
n512 n5 10 n522
Delivery system design 0.49 (0.31, 0.67) 0.76 (0.53, 0.99) 0.58 (0.44, 0.72)
n515 n5 9 n524
Clinical information systems 0.31 (0.20, 0.43) 0.54 (0.32, 0.75) 0.42 (0.28, 0.55)
n56 n5 10 n516
All interventions 0.38 (0.29, 0.46) 0.68 (0.49, 0.86) 0.46 (0.38, 0.54)
n531 n5 15 n546
RCTs: randomized controlled trials; CBAs: controlled before-and-after studies.
-0.2 0 0.2 0.4 0.6 0.8 1 1.2
Favours
control   Favours intervention 
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Studies that included organizational influence
reported the greatest reduction in HbA1c
(0.69%). It was noted that effect sizes estimated
for organizational influence and community
linkages were based on only one or two CBAs.
Therefore, these findings may be less robust than
the estimated mean effect sizes for the other
intervention components reflected in a larger
number of studies. For this reason, we mainly
compared effect sizes among the four practice-
level intervention components.
For the four practice-level intervention com-
ponents, studies involving delivery system design
had the largest reduction in HbA1c (0.58%),
followed by those with self-management support
(0.46%), decision support (0.44%) and clinical
information systems (0.42%).
As shown in Table 5, strong-quality RCTs
and CBAs reported a similar reduction in
HbA1c when compared with moderate/weak-
quality RCTs and CBAs (0.48% versus 0.44%,
P5 0.70).
Effects of different intervention components on
blood pressure control are shown in Table 6 and
Table 7. Twenty-six comparisons had sufficient
data to allow for quantitative analysis (25 with
both systolic and diastolic results and remaining
1 with systolic results only). Overall, studies
reported a mean reduction of systolic (diastolic)
blood pressure by 2.2 (1.3)mmHg. RCTs and
CBAs had similar effect sizes (P. 0.7). Studies
with intervention components of delivery system
design or self-management support were likely to
achieve greater reduction in blood pressure.
Effects of interventions on total cholesterol
control are presented in Table 8. A total of 17
comparisons had sufficient data to allow for quan-
titative analysis. Overall, studies reported a mean
reduction of 0.24mmol/L in total cholesterol.
RCTs and CBAs reported similar effect sizes (0.21
versus 0.29, P5 0.68). Studies with self-manage-
ment support components had the highest reduc-
tion in total cholesterol (0.32mmol/L).
A few studies reported the lipid profile in
terms of HDL, LDL or triglycerides, and pooled
mean effects of relevant parameters are sum-
marized as follows: (1) pooled mean increase in
HDL (95% CI) [number of studies]: 0.02mmol/L
(20.01, 0.04) [7]; (2) pooled mean reduction in
LDL: 0.12 (20.10, 0.34) [7]; and (3) pooled mean
reduction in triglycerides: 0.20 (0.07, 0.32) [8].
Associations between study features and
effect sizes
Based on meta-regression analysis, effect sizes
(including reduction in HbA1c, BP and total
cholesterol) did not differ on the basis of base-
line levels of patient outcomes, methodological
quality (strong versus moderate/weak) or the
number of intervention components (multiple
versus single).
Table 5 Effects of interventions on HbA1c (%) control by quality of studies
Intervention component Pooled mean reduction in HbA1c (95% CI), n5number of comparisons
Strong quality RCTs1CBAs Moderate/weak quality RCTs1CBAs
Organisational influence – 0.69 (0.27, 1.11)
n50 n5 2
Community linkages – 0.30 (0.28, 0.32)
n50 n5 1
Self-management support 0.53 (0.34, 0.72) 0.41 (0.32, 0.50)
n514 n5 14
Decision support 0.47 (0.33, 0.61) 0.35 (0.23, 0.47)
n57 n5 15
Delivery system design 0.50 (0.31, 0.69) 0.78 (0.49, 1.06)
n513 n5 11
Clinical information systems 0.41 (0.10, 0.72) 0.39 (0.25, 0.53)
n55 n5 11
All interventions 0.48 (0.33, 0.64) 0.44 (0.34, 0.53)
n519 n5 27
RCTs: randomized controlled trials; CBAs: controlled before-and-after studies.
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Publication bias
The reduction in HbA1c in each study is
plotted against the standard error of reduction
(Figure 3). The plot shows that, in relation to
the estimated mean effect (the vertical line), the
numbers of studies are fairly asymmetrical, indi-
cating that some studies with small or negative
effect sizes were likely not published.
Discussion
This review found that the most common CCM
components employed in trials were decision
support, self-management support, delivery sys-
tem design and clinical information systems. The
least reported CCM components were organiza-
tional influence and community linkages. Most
Table 6 Effects of different intervention components on systolic BP (mmHg) control
Intervention component Pooled mean reduction in systolic BP (95% CI), n5number of comparisons
RCTs CBAs Total
Organizational influence – – –
n50 n5 0 n50
Community linkages 8.0 (7.4, 8.6) 1.7 (1.4, 2.0) 4.8 (21.3, 11.0)
n51 n5 1 n52
Self-management support 3.4 (0.5, 6.3) 3.9 (1.3, 6.5) 3.6 (1.9, 5.3)
n511 n5 5 n516
Decision support 1.2 (20.3, 2.7) 1.6 (22.7, 6.0) 1.3 (20.3, 2.9)
n513 n5 6 n519
Delivery system design 6.4 (1.4, 11.5) 2.8 (21.8, 7.3) 4.8 (1.6, 8.0)
n55 n5 4 n59
Clinical information systems 3.2 (20.2, 6.5) 1.6 (21.4, 4.7) 2.4 (0.5, 4.2)
n55 n5 7 n512
All interventions 2.2 (0.7, 3.6) 2.3 (20.6, 5.1) 2.2 (0.9, 3.5)
n518 n5 8 n526
BP: blood pressure; RCTs: randomized controlled trials; CBAs: controlled before-and-after studies.
-2 0 2 4 6 8 10 12
Favours     
control   Favours intervention 
Table 7 Effects of different intervention components on diastolic BP (mmHg) control
Intervention component Pooled mean reduction in diastolic BP (95% CI), n5number of comparisons
RCTs CBAs Total
Organizational influence – – –
n50 n50 n50
Community linkages 2.0 (1.7, 2.3) 1.0 (0.9, 1.1) 1.5 (0.5, 2.5)
n51 n51 n52
Self-management support 1.6 (0.1, 3.0) 1.8 (0.8, 2.9) 1.7 (1.0, 2.5)
n510 n55 n515
Decision support 1.1 (20.3, 2.5) 0.8 (20.8, 2.3) 1.0 (0.1, 2.0)
n513 n56 n519
Delivery system design 1.8 (20.9, 4.6) 1.4 (0.3, 2.6) 1.6 (0.7, 2.6)
n54 n54 n58
Clinical information systems 1.6 (0.9, 2.4) 0.9 (20.1, 1.8) 1.2 (0.4, 2.0)
n55 n57 n512
All interventions 1.2 (0.1, 2.3) 1.6 (0.6, 2.6) 1.3 (0.6, 2.1)
n517 n58 n525
BP: blood pressure; RCTs: randomized controlled trials; CBAs: controlled before-and-after studies.
-2 0         2 4        6 8 10 12
Favours    
control   Favours intervention 
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trials reported using multiple components in their
interventions.
Overall, included studies suitable for quantita-
tive analysis reported small-to-moderate, statis-
tically significant improvements in a range of
patient intermediate outcomes. For example,
there was a mean reduction of 0.46% in HbA1c,
mean reduction of 2.2 (1.3)mmHg in systolic
(diastolic) blood pressure, and mean reduction of
0.24mmol/L in total cholesterol due to interven-
tions as compared to ‘usual care’.
For specific CCM components, interventions
employing delivery system design reported the
largest improvements in patient outcomes, fol-
lowed by those employing a self-management
support component. Interventions involving
decision support or clinical information systems
reported relatively smaller effect sizes.
Comparison with previous relevant reviews
Consistent with a previous review (Shojania
et al., 2004), this review showed that studies with a
randomized controlled design generally reported
smaller effect sizes than did studies with a con-
trolled before–after design. However, our data
showed that 41% of the RCTs included in this
reviews were not of high quality, and that 13% of
CBA studies were of high quality. Therefore,
it would be useful to report the findings based
on high-quality studies, irrespective of RCTs or
CBAs. Our further analysis showed that high-
quality RCTs plus high-quality CBAs reported
a similar reduction in HbA1c as compared with
moderate/low-quality RCTs and CBAs (0.48%
Table 8 Effects of different intervention components on total cholesterol (mmol/L) control
Intervention component Pooled mean reduction in total cholesterol (95% CI), n5number of comparisons
RCTs CBAs Total
Organizational influence – – –
n50 n50 n50
Community linkages 0 (20.03, 0.03) – 0 (20.03, 0.03)
n51 n50 n51
Self-management support 0.30 (20.20, 0.80) 0.35 (20.11, 0.81) 0.32 (0.04, 0.59)
n58 n54 n512
Decision support 0.27 (20.09, 0.63) 0.25 (20.24, 0.74) 0.27 (0.02, 0.51)
n56 n54 n510
Delivery system design 0.32 (20.29, 0.94) 0.10 (0.08, 0.12) 0.26 (20.15, 0.67)
n56 n52 n58
Clinical information systems 0.06 (20.02, 0.14) 0.25 (20.24, 0.74) 0.17 (20.07, 0.41)
n53 n54 n57
All interventions 0.21 (0.01, 0.43) 0.29 (20.12, 0.70) 0.24 (0.06, 0.41)
n512 n55 n517
RCTs: randomized controlled trials; CBAs: controlled before-and-after studies.
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Figure 3 An inverted funnel plot to detect publication
bias
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versus 0.44%). This mean effect size (0.48%)
reported by high-quality studies tended to be
greater than that reported by RCTs (0.38%), but
was smaller than that reported by CBAs (0.68%).
Effect sizes based on high-quality studies are
likely to be closer to true effect sizes than those
from low-quality studies.
Greater benefit of multiple interventions
over single-facet interventions has been suggested
by a meta-analysis of disease management
programmes for patients with chronic illness
(Weingarten et al., 2002). However, our meta-
regression analysis showed that effect sizes did
not differ between interventions targeting multi-
ple CCM components and those involving a single
component. Plausibly, intensity of the interven-
tions (instead of the number of intervention
components) may have an impact on the effect
sizes. However, we were unable to explore this
relationship due to the lack of explicit description
of intervention intensity from the original studies.
Our review highlighted delivery system design
as one of the most important intervention com-
ponents in achieving improvements in diabetes
care. Delivery system design included an
emphasis on role definitions for different profes-
sionals, patient care planning and regular follow-
up, and coordination between primary care and
specialist services. In a Cochrane review of dia-
betes care (Renders et al., 2001), Renders and
colleagues reported that multiple interventions in
which the role of the nurse in the follow-up of
patients was enhanced had favourable effects on
patient outcomes. In a systematic review assessing
the effectiveness of disease management (defined
as organized, proactive and integrated health care
delivery that focused on the entire spectrum of
the disease and its complications, and consistent
with our definition of delivery system design) on
diabetes care, Norris et al. (2002b) reported that
disease management interventions achieved a net
reduction of 0.5% in HbA1c (corresponding
figure in our review is 0.58%).
The effectiveness of self-management training
interventions on diabetes care has been reported
in previously published reviews (Norris et al., 2001;
2002a). In their reviews, Norris et al. (2002a)
included interventions exclusively focusing on self-
management training (education). With a median
intervention duration of 6 months, included studies
reported an average reduction of 0.76% in HbA1c
during or immediately after the intervention.
However, this effect size shrank to 0.26% four
or more months after the intervention ceased.
Furthermore, effects of self-management training
on blood pressure and lipid control were incon-
sistent (Norris et al., 2001). Considering that, in
our review, a reduction of 0.46% in HbA1c was
reported by studies using self-management sup-
port as part of multi-component interventions
(with a median duration of 1 year), it appears that
incorporating self-management support into other
intervention components is more likely to achieve
sustained improvement in diabetes care.
The review by Zwar et al. (2006) discussing the
impact of interventions using the CCM compo-
nents on a range of chronic disease showed the
evidence to be largely focused on diabetes care,
with relatively few studies of the impact on other
chronic diseases. Their findings of the impact of
interventions that addressed delivery system
design and self-management support are con-
sistent with our review findings. However, their
review did not incorporate the research evidence
on organizational influence and community lin-
kages as has been done in our review. This may
reflect a different approach to defining these two
CCM components, and highlights the need for
clearer conceptualization and description of these
components on further research.
Strengths and limitations of the
present review
The impact of different interventions on diabetes
care was assessed in terms of patient intermediate
outcomes. We examined HbA1c, blood pressure
and blood lipid control simultaneously, to reflect
advances in scientific knowledge that control of
blood pressure and blood lipids for diabetes
patients is as important as, if not more important
than, control of HbA1c in reducing micro- and
macro-vascular complications (Williams et al.,
2002); most other reviews have evaluated only
patients’ HbA1c control (Weingarten et al., 2002;
Norris et al., 2002a; 2002b; Shojania et al., 2004).
This review has several limitations. First, only
one reviewer screened search results and extracted
data for this review, and the process was repeated
to increase the reliability of data extraction.
However, the ‘gold standard’ is to have two
reviewers doing this independently. Second, due to
Effectiveness of chronic care model-oriented interventions to improve quality of diabetes care 35
Primary Health Care Research & Development 2008; 9: 25–40
complexity of the interventions and lack of detailed
description in some studies, there was potential for
misclassification of interventions in relation to the
CCM components. Third, many studies provided
insufficient detail in the method sections for us
to understand the intensity of the interventions.
For example, a study might report that patient
self-management education was used, but provide
insufficient information on the frequency of
engagement with participants and the type of pro-
cess and materials used. Fourth, this review only
indicates the relative effectiveness of different
intervention components, and the absolute effect
attributable to a particular component remains
unknown, as most included studies employed
multi-component interventions. Last, this review
found that interventions featuring the CCM com-
ponents had little effect on blood pressure control.
This finding may not reflect the true effect, because
studies considered in this review were selected on
the basis of an intervention primarily against dia-
betes rather than hypertension, and the blood
pressure outcomes may have been secondary
compared to the primary outcome of glycaemic
control. It would be useful to perform a similar
systematic review of the effectiveness of CCM-
oriented interventions on hypertension control.
Reviewer’s conclusions
Implications for practice
Overall, the findings support the concept of
the CCM in which the state of development of
various aspects of primary care service systems
defined in this model appears to be important
factors in the quality of care provided to people
with diabetes.
Implications for research
Further studies need to describe in sufficient
detail the type and dose of interventions used, to
enable others to understand and replicate them in
different settings. Importantly, studies providing
information on factors that facilitate or inhibit
implementation of interventions are particularly
useful, as such factors can be incorporated into
future intervention designs.
There is also a need for more research to be
conducted among diabetes patients from poorer
socioeconomic backgrounds, who generally
experience higher morbidity and mortality due to
diabetes. Of the studies included in this review,
only six were conducted in socioeconomically
disadvantaged populations, and only one was
conducted in an Australian Indigenous setting
(McDermott et al., 2001), highlighting the lack of
studies with direct applicability to disadvantaged
populations in specific settings.
The small number of studies of interventions
addressing organizational influence and com-
munity linkages provides less certainty on the
benefits associated with those components.
However, given the fact that studies that included
organizational influence in interventions reported
superior reduction in HbA1c (0.69%), this system
component may be of considerable importance
to accelerate improvements in chronic illness
care. There is a need for further research to
determine the significance of this component of
the CCM.
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